ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers From ASTR Meeting

November 5, 1976

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013

C. Gordon Zubrod, 84, Dies, Led Chemotherapy Research, Built Cooperative Group System

January 29, 1999

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

NIH to Hold Meeting On Faculty Design

February 2, 1996